BIT Capital’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

BIT Capital’s Portfolio RXDX Stock Details RXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-5,036	Closed	-$540K	–	184
2023 Q1	$540K	Buy	5,036 +464	+10%	+$53.4K	0.08%	87
2022 Q4	$503K	Buy	+4,572	New	+$296K	0.1%	77

Other funds holding RXDX

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

FCA

FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

BIT Capital's RXDX Position: Q2 2023 in Review

BIT Capital sold out of Prometheus Biosciences, Inc. Common Stock (RXDX) in Q2 2023, closing a stake of 5,036 shares — an estimated $540K sold.

BIT Capital first reported a position in RXDX in Q4 2022 and held it in 2 quarters. The position peaked at $540K in Q1 2023. 2 funds tracked by Wall St. Rank hold RXDX as of Q2 2023.

BIT Capital reported no remaining Prometheus Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
BIT Capital sold 5,036 Prometheus Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $540K.
BIT Capital first reported a position in Prometheus Biosciences, Inc. Common Stock in Q4 2022 and held it in 2 quarters.
BIT Capital's Prometheus Biosciences, Inc. Common Stock position peaked at $540K in Q1 2023.
2 funds tracked by Wall St. Rank held Prometheus Biosciences, Inc. Common Stock as of Q2 2023.

Based on BIT Capital's 13F filing for Q2 2023, filed 12 Feb 2025.